News Release

Zogenix to Release First Quarter 2015 Financial Results and Host Conference Call & Webcast on May 11


SAN DIEGO, May 4, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders, today announced that it will report its financial results for the first quarter ended March 31, 2015 after the market close, and will host a corporate update conference call and webcast on Monday, May 11, 2015 at 4:30pm Eastern Time.

Monday, May 11, 2015 @ 4:30pm Eastern Time/1:30pm Pacific
Toll Free: 888-430-8694
International: 719-325-2308
Conference ID:  6728810
Replays, available through May 25, 2015
Toll Free: 877-870-5176
International: 719-325-2472
Conference ID:  6728810

About Zogenix

Zogenix, Inc. (ZGNX) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.

CONTACT: Catherine O'Connor
         Sr. Director, Corporate Communications
         Zogenix, Inc.

         Andrew McDonald
         Founding Partner
         LifeSci Advisors, LLC
Zogenix, Inc.